Figure 3 | Modern Pathology

Figure 3

From: Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?

Figure 3

BAF250a expression in ovarian carcinomas. Immunohistochemical staining of ARID1A/BAF250a in ovarian carcinomas. (a) Example of strong nuclear expression in a high-grade serous carcinoma ( × 200). (b) Moderate intense expression in a mucinous carcinoma ( × 200). (c–e) Loss of expression in an endometrioid carcinoma (c, × 200), in a clear cell carcinoma (d, × 200), in a mucinous carcinoma (e, × 200) and a serous carcinoma (f, × 200). Note that only stromal cells show immunoreactivity.

Back to article page